Economic burden for women's diseases tops $500 billion, but women’s health makes up about 4 percent of total R&D funding for healthcare products and services.
Online ExclusivesHrishikesh Kadam, Research Content Developer, Global Market Insights (GMI)12.11.19
DDR, an enhanced X-ray technology, enables clinicians to analyze and quantify the interaction of anatomical structures with physiological changes over time.
The SpHb tracked changes in hemoglobin satisfactorily during surgery and more accurately estimated the appropriate timing for invasive hemoglobin measurements.
Study objective is to employ an investigational iteration of the Lucid Robotic System to gather and further explore the technical feasibility of the technology.